Concepts and strategies in new drug development:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
New York u.a.
Praeger
1983
|
| Series: | Clinical pharmacology and therapeutics series
4 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XIV, 265 S. |
| ISBN: | 0030692873 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000173581 | ||
| 003 | DE-604 | ||
| 005 | 20090514 | ||
| 007 | t | ||
| 008 | 870612s1983 |||| 00||| eng d | ||
| 020 | |a 0030692873 |9 0-03-069287-3 | ||
| 035 | |a (OCoLC)10020709 | ||
| 035 | |a (DE-599)BVBBV000173581 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a QV771 C744 1982 | |
| 050 | 0 | |a RS189 | |
| 082 | 0 | |a 615/.1/072 |2 19 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 245 | 1 | 0 | |a Concepts and strategies in new drug development |c ed. by Peter U. Nwangwu |
| 264 | 1 | |a New York u.a. |b Praeger |c 1983 | |
| 300 | |a XIV, 265 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Clinical pharmacology and therapeutics series |v 4 | |
| 650 | 2 | |a Essais cliniques comme sujet | |
| 650 | 2 | |a Évaluation médicament | |
| 650 | 4 | |a Clinical Trials as Topic |v Congresses | |
| 650 | 4 | |a Drug Evaluation |v Congresses | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Pharmacy | |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Nwangwu, Peter U. |e Sonstige |4 oth | |
| 830 | 0 | |a Clinical pharmacology and therapeutics series |v 4 |w (DE-604)BV000010293 |9 4 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099273&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000099273 | ||
Record in the Search Index
| _version_ | 1804114633316892672 |
|---|---|
| adam_text | ORE S CONCEPTS AND STRATEGIES IN NEW DRUG DEVELOPMENT UNIVERSIT.8TS
B BLIOTHETC EDITED BY PETER U. NWANGWU CLINICAL PHARMACOLOGY AND
THERAPEUTICS SERIES VOLUME 4 PRAEGER SPECIAL STUDIES * PRAEGER
SCIENTIFIC N E W Y O R K * P H I L A D E L P H I A * E A S T B O U R N E
, U K T O R O N T O * H O N G K O N G * T O K Y O * S Y D N E Y CONTENTS
LIST OF CONTRIBUTORS V PREFACE VII ACKNOWLEDGMENTS XI CHAPTER 1 THE
PROCESS OF NEW DRUG DEVELOPMENT: CURRENT DEFICIENCIES AND OPPORTUNITIES
FOR IMPROVEMENT PETER U. NWANGWU 1 2 IMPORTANT CONSIDERATIONS FOR THE
CLINICAL EVALUATION OF DRUGS: APPROPRIATE DOSING REGIMENS MARION J.
HNKEL 17 3 RESOLVING ETHICAL AND MORAL PROBLEMS IN CLINICAL TRIALS
VINCENT DEPAUL LYNCH 23 4 COPING WITH REGULATIONS AND LEGAL ASPECTS OF
CLINICAL TRIALS HAROLD L. HOWES, JR. ^ 63 5 PRACTICAL INSIGHTS ON
DESIGNING THE CORRECT PROTOCOL-PHASES I, II, III, AND IV ALLEN CATO 79 6
IMPORTANT STATISTICAL CONSIDERATIONS IN TRIAL DESIGN MARTIN O CONNELL 98
7 THE LOGISTICS OF CLINICAL TRIALS JOHN J. DONAHUE 109 8 VOLUNTEER
STUDIES AND HUMAN PHARMACOLOGY- PHASE I FRANCES O. KELSEY 123 XIII
CHAPTER PAGE 9 CLINICAL TRIALS-PHASE II AND III KENNETH G. ROTHWELL 134
10 OPTIMIZING DATA COLLECTION AND ANALYSIS NOEL R. MOHBERG 140 11
EFFECTIVE ADVERSE REACTION MONITORING KENNETH M. GIVEN 157 12 ESSENTIALS
OF BIOAVAILABILITY STUDIES . SANFORD M. BOLTON 167 13 HOW TO PREPARE
EFFECTIVE IND AND NDA PAUL M. WORRAL 212 14 PRACTICAL PERSPECTIVES ON
POSTMARKETING SURVEILLANCE*PHASE IV STANLEY EDLAVITCH 223 15 PRACTICE
AND APPLICATION OF GOOD CLINICAL PRACTICES RICHARD A. GUARINO 243 INDEX
259 XIV
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV000173581 |
| callnumber-first | Q - Science |
| callnumber-label | QV771 C744 1982 |
| callnumber-raw | QV771 C744 1982 RS189 |
| callnumber-search | QV771 C744 1982 RS189 |
| callnumber-sort | QV 3771 C744 41982 |
| classification_rvk | VS 5350 |
| ctrlnum | (OCoLC)10020709 (DE-599)BVBBV000173581 |
| dewey-full | 615/.1/072 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1/072 |
| dewey-search | 615/.1/072 |
| dewey-sort | 3615 11 272 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01934nam a2200505 cb4500</leader><controlfield tag="001">BV000173581</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090514 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1983 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0030692873</subfield><subfield code="9">0-03-069287-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)10020709</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000173581</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QV771 C744 1982</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1/072</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Concepts and strategies in new drug development</subfield><subfield code="c">ed. by Peter U. Nwangwu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Praeger</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 265 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Clinical pharmacology and therapeutics series</subfield><subfield code="v">4</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Essais cliniques comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Évaluation médicament</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nwangwu, Peter U.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Clinical pharmacology and therapeutics series</subfield><subfield code="v">4</subfield><subfield code="w">(DE-604)BV000010293</subfield><subfield code="9">4</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099273&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000099273</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV000173581 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:09:49Z |
| institution | BVB |
| isbn | 0030692873 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000099273 |
| oclc_num | 10020709 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XIV, 265 S. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | Praeger |
| record_format | marc |
| series | Clinical pharmacology and therapeutics series |
| series2 | Clinical pharmacology and therapeutics series |
| spelling | Concepts and strategies in new drug development ed. by Peter U. Nwangwu New York u.a. Praeger 1983 XIV, 265 S. txt rdacontent n rdamedia nc rdacarrier Clinical pharmacology and therapeutics series 4 Essais cliniques comme sujet Évaluation médicament Clinical Trials as Topic Congresses Drug Evaluation Congresses Drug development Pharmacy Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Arzneimittelprüfung (DE-588)4128030-1 s Nwangwu, Peter U. Sonstige oth Clinical pharmacology and therapeutics series 4 (DE-604)BV000010293 4 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099273&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Concepts and strategies in new drug development Clinical pharmacology and therapeutics series Essais cliniques comme sujet Évaluation médicament Clinical Trials as Topic Congresses Drug Evaluation Congresses Drug development Pharmacy Arzneimittelprüfung (DE-588)4128030-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4128030-1 (DE-588)4143176-5 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Concepts and strategies in new drug development |
| title_auth | Concepts and strategies in new drug development |
| title_exact_search | Concepts and strategies in new drug development |
| title_full | Concepts and strategies in new drug development ed. by Peter U. Nwangwu |
| title_fullStr | Concepts and strategies in new drug development ed. by Peter U. Nwangwu |
| title_full_unstemmed | Concepts and strategies in new drug development ed. by Peter U. Nwangwu |
| title_short | Concepts and strategies in new drug development |
| title_sort | concepts and strategies in new drug development |
| topic | Essais cliniques comme sujet Évaluation médicament Clinical Trials as Topic Congresses Drug Evaluation Congresses Drug development Pharmacy Arzneimittelprüfung (DE-588)4128030-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Essais cliniques comme sujet Évaluation médicament Clinical Trials as Topic Congresses Drug Evaluation Congresses Drug development Pharmacy Arzneimittelprüfung Arzneimittelentwicklung Aufsatzsammlung Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099273&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000010293 |
| work_keys_str_mv | AT nwangwupeteru conceptsandstrategiesinnewdrugdevelopment |